Resonance Specialties Limited (BOM:524218)
95.65
+1.50 (1.59%)
At close: Jan 22, 2026
Resonance Specialties Revenue
Resonance Specialties had revenue of 215.34M INR in the quarter ending September 30, 2025, with 19.20% growth. This brings the company's revenue in the last twelve months to 852.48M, up 27.11% year-over-year. In the fiscal year ending March 31, 2025, Resonance Specialties had annual revenue of 778.07M with 40.70% growth.
Revenue (ttm)
852.48M
Revenue Growth
+27.11%
P/S Ratio
1.30
Revenue / Employee
12.92M
Employees
66
Market Cap
1.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 778.07M | 225.06M | 40.70% |
| Mar 31, 2024 | 553.01M | -35.14M | -5.97% |
| Mar 31, 2023 | 588.15M | -169.43M | -22.36% |
| Mar 31, 2022 | 757.57M | 48.62M | 6.86% |
| Mar 31, 2021 | 708.95M | 136.07M | 23.75% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Aarey Drugs & Pharmaceuticals | 4.28B |
| Infinium Pharmachem | 1.57B |
| Kimia Biosciences | 1.26B |
| Smruthi Organics | 1.20B |
| Panchsheel Organics | 1.03B |
| Tyche Industries | 570.25M |
| Vasundhara Rasayans | 329.60M |